N-acetyl-5-hydroxytryptamine,
N-acetylhydroxytryptamine,
N-acetylserotonin,
N-Acetyl-5-hydroxytryptamine,
N-acetylserotonin,
1210-83-9,
Normelatonin,
N-ACETYL SEROTONIN,
N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]acetamide,
O-Demethylmelatonin,
acetylserotonin,
5-Hydroxy-N-acetyltryptamine,
UNII-P4TO3C82WV,
Acetyl-5-hydroxy-tryptamine,
5-Hydroxymelatonin,
N-(2-(5-Hydroxy-1H-indol-3-yl)ethyl)acetamide,
3-(2-Acetamidoethyl)-5-hydroxyindole,
P4TO3C82WV,
CHEMBL33103,
CHEBI:17697,
MVAWJSIDNICKHF-UHFFFAOYSA-N,
Acetamide, N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-,
MFCD00005656,
A-1300,
Desmethylmelatonin,
N-acetyl-serotonin,
Serotonin,N-acetyl,
N-acetyl serotonine,
EINECS 214-916-5,
N-acetyl-5-HT,
Serotonin, N-acetyl-,
Spectrum_000369,
AC1L1AAB,
Spectrum3_001871,
Spectrum4_001268,
Spectrum5_000975,
Lopac-A-1824,
ACMC-1BO7I,
AC1Q5P6T,
Acetamide, N-[2-(5-hydroxyindol-3-yl)ethyl]-,
Lopac0_000044,
BSPBio_003342,
KBioGR_001856,
KBioSS_000849,
N-Acetyltryptamine,5-Hydroxy,
MLS000859911,
DivK1c_000668,
SCHEMBL422165,
SPECTRUM1500700,
AC1Q1L67,
AC1Q1L68,
GTPL5451,
N-Acetylserotonin; Normelatonin,
BDBM29612,
CTK8A9435,
HMS502B10,
KBio1_000668,
KBio2_000849,
KBio2_003417,
KBio2_005985,
KBio3_002844,
N-Acetylserotonin|||Normelatonin,
ZINC66104,
DTXSID00153106,
Tryptamine, N-acetyl-5-hydroxy-,
NINDS_000668,
HMS2235E22,
HMS3260I09,
HMS3372M05,
N-Acetyl-5-hydroxytryptamine, 99%,
Tox21_500044,
7506AH,
ANW-17558,
PDSP1_001650,
PDSP1_001789,
PDSP1_001790,
PDSP1_001827,
PDSP2_001634,
PDSP2_001772,
PDSP2_001773,
PDSP2_001810,
AKOS004120085,
API0003477,
CCG-204140,
DB04275,
LP00044,
MCULE-4114943625,
VZ33043,
IDI1_000668,
NCGC00015039-01,
NCGC00015039-02,
NCGC00015039-03,
NCGC00015039-04,
NCGC00015039-05,
NCGC00015039-06,
NCGC00015039-07,
NCGC00093558-01,
NCGC00093558-02,
NCGC00093558-03,
NCGC00093558-04,
NCGC00093558-05,
NCGC00260729-01,
CC-32273,
SMR000326772,
ST092857,
ZB002533,
DB-007732,
HY-107854,
TC-106303,
A1277,
CS-0030736,
EU-0100044,
FT-0080684,
FT-0629855,
N-[2-(5-hydroxyindol-3-yl)ethyl]acetamide,
A 1824,
C00978,
A804654,
C-11937,
L000433,
N-(2-(5-hydroxy-1H-indol-3-yl)ethyl) acetamide,
SR-01000075660,
Acetamide,N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-,
I10-0829,
N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]acetamide #,
N-[2-(5-oxidanyl-1H-indol-3-yl)ethyl]ethanamide,
SR-01000075660-1,
BRD-K26140483-001-01-3,
N-Acetyl-5-hydroxytryptamine, >=99% (TLC), powder,
7D6F82BE-C205-424F-9F26-65CE227610C0,
N-acetylhydroxytryptamine,
D00PDI,
D0F9ZW,
C12H14N2O2,
CID903,
AR-1G8546,
RW1710,
ZINC00066104,
C12-H14-N2-O2,
C006389,
N-[2-(5-Hydroxy-1H-indol-3-yl)-ethyl]-acetamide,
ASE,
17994-17-1,
18304-13-7,
Nas,